BeOne Medicines
ONC
#780
Rank
C$43.27 B
Marketcap
C$417.13
Share price
-3.77%
Change (1 day)
35.67%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$6.65

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$6.59. In 2025 the company made an earnings per share (EPS) of C$3.74 an increase over its 2024 EPS that were of C-$8.54.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.6577.86%
2025C$3.74-143.75%
2024C-$8.54
2022C-$26.7028.21%
2021C-$20.83-19.96%
2020C-$26.0220.81%
2019C-$21.5431.52%
2018C-$16.38417.57%
2017C-$3.16-37.16%
2016C-$5.04158.95%
2015C-$1.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.33-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.30-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA